U.S. Markets close in 3 hrs 43 mins

Recro Pharma (REPH) in Focus: Stock Gains 6.5%

Zacks Equity Research

Recro Pharma, Inc. (REPH) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $6.02 to $7.28.

This clinical stage specialty pharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Recro Pharma currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the Med-Drugs industry may consider better-ranked stocks like Aeolus Pharmaceuticals Inc. (AOLS), Ariad Pharmaceuticals Inc. (ARIA) and Ohr Pharmaceutical, Inc. (OHRP). All the three stocks sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

RECRO PHARMA INC (REPH): Free Stock Analysis Report

AEOLUS PHARMACEUTICL (AOLS): Free Stock Analysis Report


OHR PHARMACEUTICAL INC (OHRP): Free Stock Analysis Report

Zacks Investment Research